The drug is still in clinical trials and lacks FDA approval, yet CBS News finds it promoted across the internet to people seeking weight loss.
Recap by typeshit. Video by @cbsnews on TikTok.
The actor backed Ozempic in an interview while saying exercise has no shortcut. Doctors break down whether his advice holds up.
A BusinessWorld piece on FDA worries about unapproved GLP-1 weight loss drugs, including retatrutide, which is still in trials. Few details were available.
Hecht walks through studies raising concerns that Ozempic and Wegovy may be tied to a rare optic nerve problem that can affect vision.
After his appetite disappeared on tirzepatide, Krasno talks with the Your Best Shot author about food and why scale weight can mask muscle, bone and testosterone loss.
Oddo moved to DKK 305 and HSBC to DKK 280. Novo also shared a CagriSema subgroup analysis showing women lost 25% of body weight at 68 weeks.
Hermida shares that emerging research suggests GLP-1 medications could have effects beyond obesity and diabetes. A short post with few specifics.
Loading…